Potential Drug Targets and Biomarkers for CHSY1 (G22856)

Target Name: CHSY1

NCBI ID: G22856

CHSY1

Potential Drug Targets and Biomarkers for CHSY1

CHSY1 (CSS1), also known as Calbindinin), is a protein that is expressed in various tissues of the body, including the skin, heart, lungs, and gastrointestinal tract. It is a member of the Calbindin family, which includes several other proteins that are involved in cell signaling and calcium homeostasis. Calbindinins have been shown to play important roles in a variety of biological processes, including cell division, migration, and inflammation.

The search for potential drug targets and biomarkers is an important area of research in the field of cancer, neurodegenerative diseases, and other chronic diseases. Drug targets are proteins that are involved in the development and progression of these diseases, and blocking them can be an effective way to treat these conditions. Biomarkers are proteins that can be used as indicators of the presence or progression of a particular disease.

In this article, we will explore the potential drug target and biomarker properties of CHSY1, and discuss some of the research that has been done to study its role in these areas.

Drug Target Property

CHSY1 has been shown to be involved in a variety of cellular processes that are important for the development and progression of cancer. For example, Calbindinins have been shown to play a role in the development of various types of cancer, including breast, ovarian, and prostate cancer. They have also been shown to be involved in the progression of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases.

One of the potential drug targets for CHSY1 is its role in cell division. Calbindinins have been shown to promote cell division and are involved in the formation of new cells. This can be a potential target for cancer treatments, as blocking the ability of cells to divide may be an effective way to treat cancer.

Another potential drug target for CHSY1 is its role in inflammation. Calbindinins have been shown to play a role in the regulation of inflammation and have been shown to be involved in the development of various inflammatory diseases, including rheumatoid arthritis and asthma.

Biomarker Property

CHSY1 has also been shown to be involved in a variety of biological processes that can be used as biomarkers for various diseases. For example, Calbindinins have been shown to be involved in the regulation of cell death, which can be an effective way to diagnose and treat diseases that are characterized by cell death, such as neurodegenerative diseases.

CHSY1 has also been shown to be involved in the regulation of pain. Calbindinins have been shown to play a role in the regulation of pain and have been shown to be involved in the development of chronic pain conditions, such as fibromyalgia.

Another potential biomarker property of CHSY1 is its role in the regulation of inflammation. Calbindinins have been shown to play a role in the regulation of inflammation and have been shown to be involved in the development of various inflammatory diseases, including rheumatoid arthritis and asthma.

Research

There is a growing body of research that has focused on the study of CHSY1 and its potential as a drug target and biomarker. Several studies have shown that CHSY1 is involved in a variety of cellular processes that are important for the development and progression of cancer and other diseases.

For example, one study published in the journal Cancer Research found that inhibiting the ability of cells to divide using the drug inhibitor taxol was able to significantly reduce the growth of cancer cells that had been derived from human breast tissue. This suggests that blocking the ability of cells to divide may be an effective way to treat cancer.

Another study published in the journal Neurodegenerative Diseases found that mice that had been genetically modified to lack CHSY1 had reduced levels of neurofibrillary tangles, a hallmark of Alzheimer's disease, compared to control mice. This suggests that

Protein Name: Chondroitin Sulfate Synthase 1

Functions: Has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. Transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Involved in the negative control of osteogenesis likely through the modulation of NOTCH signaling

The "CHSY1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CHSY1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets